1 |
Zhu J, Wilding JPH, Hu J. Adipocytes in obesity: A perfect reservoir for SARS-CoV-2? Med Hypotheses 2023;171:111020. [PMID: 36742015 DOI: 10.1016/j.mehy.2023.111020] [Reference Citation Analysis]
|
2 |
Nadwa EH, Al-Kuraishy HM, Al-Gareeb AI, Elekhnawy E, Albogami SM, Alorabi M, Batiha GE, De Waard M. Cholinergic dysfunction in COVID-19: frantic search and hoping for the best. Naunyn Schmiedebergs Arch Pharmacol 2023;396:453-68. [PMID: 36460816 DOI: 10.1007/s00210-022-02346-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
3 |
Batiha GE, Al-Kuraishy HM, Al-Gareeb AI, Alruwaili M, AlRuwaili R, Albogami SM, Alorabi M, Saad HM, Simal-Gandara J. Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal. Inflammopharmacology 2023;31:1-7. [PMID: 36418600 DOI: 10.1007/s10787-022-01087-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
4 |
Al-Kuraishy HM, Al-Gareeb AI, Albezrah NKA, Bahaa HA, El-Bouseary MM, Alexiou A, Al-Ziyadi SH, Batiha GE. Pregnancy and COVID-19: high or low risk of vertical transmission. Clin Exp Med 2022. [PMID: 36251144 DOI: 10.1007/s10238-022-00907-z] [Reference Citation Analysis]
|
5 |
Al-Kuraishy HM, Issa HK, Al-Gareeb AI, El-Bouseary MM, Youssef A, Abdelaziz AS, Khalifa HA, Batiha GE. The role of ivabradine in doxorubicin-induced cardiotoxicity: exploring of underlying argument. Inflammopharmacology 2022. [PMID: 36219320 DOI: 10.1007/s10787-022-01082-z] [Reference Citation Analysis]
|
6 |
Alomair BM, Al-kuraishy HM, Al-gareeb AI, Al-hamash SM, De Waard M, Sabatier J, Saad HM, El-saber Batiha G. Montelukast and Acute Coronary Syndrome: The Endowed Drug. Pharmaceuticals 2022;15:1147. [DOI: 10.3390/ph15091147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
7 |
Al-Kuraishy HM, Al-Gareeb AI, Al-Maiahy TJ, Alexiou A, Mukerjee N, Batiha GE. Prostaglandins and non-steroidal anti-inflammatory drugs in Covid-19. Biotechnol Genet Eng Rev 2022;:1-21. [PMID: 36098621 DOI: 10.1080/02648725.2022.2122290] [Reference Citation Analysis]
|
8 |
Babalghith AO, Al-Kuraishy HM, Al-Gareeb AI, De Waard M, Sabatier JM, Saad HM, Batiha GE. The Potential Role of Growth Differentiation Factor 15 in COVID-19: A Corollary Subjective Effect or Not? Diagnostics (Basel) 2022;12:2051. [PMID: 36140453 DOI: 10.3390/diagnostics12092051] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
9 |
Al-kuraishy HM, Al-gareeb AI, Al-hamash SM, Cavalu S, El-bouseary MM, Sonbol FI, Batiha GE. Changes in the Blood Viscosity in Patients With SARS-CoV-2 Infection. Front Med 2022;9:876017. [DOI: 10.3389/fmed.2022.876017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|